Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling
Chien‐Tai Hong(Taipei Medical University-Shuang Ho Hospital), Oluwaseun Adebayo Bamodu(Muhimbili University of Health and Allied Sciences), Chaur‐Jong Hu(Taipei Medical University-Shuang Ho Hospital), Kai‐Yin Chau(National Hospital for Neurology and Neurosurgery), Weu Wang(Taipei Medical University), Kai‐Yun Chen(Nanchang University), Jing-Yuan Chiu(Taipei Medical University), Tsu-Yi Chao(Ministry of Health and Welfare), Dean Wu(Unknown)
Cited by 131
Related Papers
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
|Human Molecular Genetics|2010|896
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
|Brain|2014|321
Mitochondrial and lysosomal biogenesis are activated following <scp>PINK</scp>1/parkin‐mediated mitophagy
|Journal of Neurochemistry|2015|256